High serum levels of soluble interleukin-2 receptor in acute myeloid leukemia: Correlation with poor prognosis and CD4 expression on blast cells
Authors:
- Kazunori NakaseKNKazunori Nakase
- Kenkichi KitaKKKenkichi Kita
- Taiichi KyoTKTaiichi Kyo
- Kota TsujiKTKota Tsuji
- Naoyuki KatayamaNKNaoyuki Katayama
- 1 October 2012
- journal article
- Published by Elsevier in Cancer Epidemiology
- Vol. 36 (5) , e306-e309
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Clinical and prognostic significance of cytokine receptor expression in adult acute lymphoblastic leukemia: interleukin-2 receptor α-chain predicts a poor prognosisLeukemia, 2007
- Elevated levels of soluble interleukin-2 receptor in serum of patients with hematological or non-hematological malignanciesCancer Detection Prevention, 2005
- Cooperative oncology groups in Japan: Experience from the Japan Adult Leukemia Study GroupCancer Chemotherapy and Pharmacology, 1998
- Significance of soluble interleukin-2 receptor levels for evaluation of the progression of adult T-cell leukemiaCancer, 1994
- The IL-2/IL-2 Receptor System. Involvement of a Novel Receptor Subunit, .GAMMA. Chain, in Growth Signal Transduction.The Tohoku Journal of Experimental Medicine, 1992
- Serum interleukin-2 receptor as index of tumor burden in hairy cell leukemia [letter; comment]Blood, 1991
- Increased Levels of Soluble lnterleukin-2 Receptor in Non-Hodgkin’s Lymphomas: Relationship with Clinical, Histologic, and Phenotypic FeaturesAmerican Journal of Clinical Pathology, 1989
- Serum interleukin 2 receptor levels in childhood acute lymphoblastic leukemiaBlood, 1988
- High serum levels of soluble interleukin 2 receptor in patients with B chronic lymphocytic leukemiaBlood, 1987
- Soluble interleukin-2 receptors in the serum of patients with Hodgkin's diseaseBritish Journal of Cancer, 1987